Identification of miRSNPs associated with the risk of multiple myeloma.
View/ Open
Date
2017-02-01ICR Author
Author
Macauda, A
Calvetti, D
Maccari, G
Hemminki, K
Försti, A
Goldschmidt, H
Weinhold, N
Houlston, R
Andersen, V
Vogel, U
Buda, G
Varkonyi, J
Sureda, A
Martinez Lopez, J
Watek, M
Butrym, A
Sarasquete, ME
Dudziński, M
Jurczyszyn, A
Druzd-Sitek, A
Kruszewski, M
Subocz, E
Petrini, M
Iskierka-Jażdżewska, E
Raźny, M
Szombath, G
Marques, H
Zawirska, D
Chraniuk, D
Halka, J
Hove Jacobsen, SE
Mazur, G
García Sanz, R
Dumontet, C
Moreno, V
Stępień, A
Beider, K
Pelosini, M
Manuel Reis, R
Krawczyk-Kulis, M
Rymko, M
Avet-Loiseau, H
Lesueur, F
Grząśko, N
Ostrovsky, O
Jamroziak, K
Vangsted, AJ
Jerez, A
Tomczak, W
Zaucha, JM
Kadar, K
Sainz, J
Nagler, A
Landi, S
Gemignani, F
Canzian, F
Type
Journal Article
Metadata
Show full item recordAbstract
Multiple myeloma (MM) is a malignancy of plasma cells usually infiltrating the bone marrow, associated with the production of a monoclonal immunoglobulin (M protein) which can be detected in the blood and/or urine. Multiple lines of evidence suggest that genetic factors are involved in MM pathogenesis, and several studies have identified single nucleotide polymorphisms (SNPs) associated with the susceptibility to the disease. SNPs within miRNA-binding sites in target genes (miRSNPs) may alter the strength of miRNA-mRNA interactions, thus deregulating protein expression. MiRSNPs are known to be associated with risk of various types of cancer, but they have never been investigated in MM. We performed an in silico genome-wide search for miRSNPs predicted to alter binding of miRNAs to their target sequences. We selected 12 miRSNPs and tested their association with MM risk. Our study population consisted of 1,832 controls and 2,894 MM cases recruited from seven European countries and Israel in the context of the IMMEnSE (International Multiple Myeloma rESEarch) consortium. In this population two SNPs showed an association with p < 0.05: rs286595 (located in gene MRLP22) and rs14191881 (located in gene TCF19). Results from IMMEnSE were meta-analyzed with data from a previously published genome-wide association study (GWAS). The SNPs rs13409 (located in the 3'UTR of the POU5F1 gene), rs1419881 (TCF19), rs1049633, rs1049623 (both in DDR1) showed significant associations with MM risk. In conclusion, we sought to identify genetic polymorphisms associated with MM risk starting from genome-wide prediction of miRSNPs. For some mirSNPs, we have shown promising associations with MM risk.
Collections
Subject
Humans
Multiple Myeloma
Genetic Predisposition to Disease
Myeloma Proteins
MicroRNAs
RNA, Messenger
3' Untranslated Regions
Risk
Case-Control Studies
Binding Sites
Genotype
Polymorphism, Single Nucleotide
Adult
Aged
Middle Aged
Europe
Female
Male
Genome-Wide Association Study
Research team
Cancer Genomics
Language
eng
Date accepted
2016-08-24
License start date
2017-02
Citation
International journal of cancer, 2017, 140 (3), pp. 526 - 534
Publisher
WILEY-BLACKWELL